ARLINGTON, Tenn.--(BUSINESS WIRE)--MicroPort Orthopedics Inc. (“MicroPort Orthopedics”) announced today the launch of the Profemur® Preserve® Hip Stem (“Profemur® Preserve®”), a short stem designed to support today’s growing market of bone and tissue preserving surgical techniques. “As physicians evaluate the landscape of short stems, Profemur® Preserve® is attractively positioned to capture market share,” said Patrick Gregory, Hip Product Manager for MicroPort Orthopedics. Short stems have grown in popularity as physicians give additional consideration to tissue-friendly approaches and ongoing care for a younger patient population. Shorter stems preserve bone, which facilitates future revisions through a wider range of treatment options.
“Managing OR flow and consistency are central initiatives for MicroPort Orthopedics as we bring new products to the market”
Preserve Classic was designed to maximize head center coverage with the fewest number of SKUs resulting in an optimized stem with virtually no technique learning curve. Preserve® Classic and Preserve® Modular are part of MicroPort Orthopedics’ Simply Versatile™ platform which allows surgeons the flexibility of using classic and modular stems utilizing the same surgical technique with a common set of instruments. “Managing OR flow and consistency are central initiatives for MicroPort Orthopedics as we bring new products to the market,” said Gregory.
Performing the first two hip replacement surgeries with Profemur® Preserve® is Dr. Phillip Merritt, Direct Anterior Approach Specialist, Glendale, California.
About MicroPort Orthopedics
Established in January 2014, MicroPort Orthopedics Inc. is the fourth largest multinational producer of orthopedic products, and a proud member of the MicroPort Scientific Corporation family of companies. From its headquarters in Arlington, Tennessee, MicroPort Orthopedics develops, produces and distributes innovative OrthoRecon products. The company’s U.S.-based manufacturing and logistics capabilities deliver high quality hip and knee products to patients and their doctors in over 60 countries, including the U.S., EMEA, Japanese, Latin American and China markets. For more information about MicroPort Orthopedics, visit www.ortho.microport.com.
MicroPort Scientific Corporation is a leading medical device company focused on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 20 seconds in thousands of major hospitals around the world, MicroPort maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient-oriented global enterprise that improves and reshapes patient lives through application of innovative science and technology. For more information, please refer to: www.microport.com.
Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words “believe,” “intend,” “expect,” “anticipate,” “project,” “estimate,” “predict,” “is confident,” “has confidence” and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort’s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.
This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.
All rights reserved.
Copyright © 2015 MicroPort Scientific Corporation